100 Percent Art,It takes a couple of months to get an FDA meeting. BIEL submitted their Pre-Submission documents and scheduled the 5/29 meeting to go over the details and any changes the FDA might request.
The FDA got back to BIEL and said, Your RecoveryRx Pre-Submission data looks good proceed with a 510k application. There was no need for the meeting, FDA gave the Green Light based on BIEL's Pre-Submission materials.
"Upon its review of the submitted information the FDA has provided written feedback and guidance for a 510(k) application to obtain expanded market clearance for treatment of postoperative pain."
We have the same outcome as after the 5/9 Back Pain Pre-Submission Meeting except the FDA saved the time and expense of the meeting by approving the 510k Path for RecoveryRx via the Pre-Submission data.